UNPARALLELED DATA EXPLORATION

Reinventing Life Sciences Innovation

 
unsplash-image-Ig1YHgmJrnQ.jpg

challenge

Slow Discovery and Research Process for Life-Saving Projects

 

Competitive landscape, complex protocols, and high risk investments hinder the innovation process.

 

Fragmented data assets, limited access to clinical information and long timelines are limiting factors for life science organizations striving to innovate. At MDClone, we understand that gaps and limitations in data impact discoveries, outcomes, and revenue.

 
 
 

solution

Move Science Forward with Confidence and Speed

Accelerate the research and discovery process with informed decision-making.

MDClone connects life science organizations to rich patient data needed to test hypotheses, build models, validate studies, develop clinical trials, improve care optimization, and create life-saving therapies. Through a secure and controlled platform with embedded synthetic data technology, life science organizations are able to identify sites, analyze robust structured and unstructured real-world data, and explore populations of interest with incredible detail and flexibility.

EXPLORE THE connect PLATFORM →

background-graphic_challenge-solution-06.png

Integrate Seamlessly with Healthcare Systems from Around the World 

On a Mission to Transform Healthcare

The Global Network is an international, member-driven collaborative of leading healthcare systems determined to improve patient care. Through the power of community, these organizations are striving to shape the future of health and wellness with rapid, data-driven learning, collaboration, and innovation at the forefront.

Connecting Life Sciences and Healthcare Systems 

With The Global Network’s world-class healthcare systems, life science organizations have access to large data sets, partnerships, information, and expert teams.

 
 
 
 

Explore High-Quality, Rich Data Instantly and Dynamically

Leverage Synthetic Data for Projects of Interest

Leverage MDClone’s powerful synthetic capabilities to explore robust synthetic data — preserved either longitudinally or in context — to get the information needed without barriers or limitations.

Target granular data

Determine if subject populations are sufficient before committing to traditional data access processes. Query, adjust, and analyze populations of interest to build out projects with confidence.

 
 

Shorten Timelines for Discovery and Development

Bring breakthrough therapies to patients faster

By accessing real-world data from the source, inside a health system, life science organizations can identify promising patient cohorts for post-marketing analysis.


Validate findings Against Real Data

After exploring synthetic data, validate results against original data to verify conclusions for submission, publication, or patient care.

 
backgrounds_1920x3600-05.png
  • Quickly identify descriptive variables of interest along longitudinal patient timelines to understand the utilization of care for specific disease groups.

  • Define cohorts of patients with particular diseases and utilize synthetic data sets to examine the entire patient journey in order to recommend earlier intervention protocols. Build multivariate prediction models and develop risk scores based on findings.

  • Ensure patients are receiving optimal treatment by understanding and disseminating information about guidelines for new and in-line medications.

  • Dynamically apply inclusion and exclusion criteria for clinical trials against real-world patient populations to estimate the size of the potential subject pool, time to complete recruitment, and unanticipated confounders in the population.

  • Develop tools, applications, and services for clinical decision support to identify gaps in care, missed diagnoses, failures in compliance, and suboptimal treatment plans.

  • Within seconds, view an estimate of the patient cohort size to understand the potential subject population and site criteria. Further define and refine exclusion and inclusion criteria with details only available through synthetic data.

 

Demonstrate Value Across the Entire Life Sciences Spectrum

With real-world evidence and robust data at your fingertips, confidently move forward with research and projects of interest. Answer complex healthcare questions quickly, explore data on-demand, and seamlessly interact with all data elements within the confines of a use case.

backgrounds-17-x.png

Unlock a Powerful, Global Healthcare Network 

Join the largest network of global health systems committed to working together to accelerate innovation and improve patient care.

Together, these organizations understand that shared insights, teamwork, and research partnerships are key to shaping the future of health and wellness.

LEARN MORE ABOUT THE MEMBERS →

 
 
 

committed to preserving patient privacy

Privacy is Our Top Priority

With patient privacy and security at the forefront, the Connect Platform enables dynamic data access and project collaboration between multiple organizations with controls in place to ensure privacy for patients, security for healthcare systems, and protections for insights generated by life science organizations.

Rather than utilizing traditional de-identified data, users access synthetic data, which provide researchers with artificially created, computationally derived data that replicate the statistical characteristics and correlations of real-world data.

Because synthetic data is created as a brand new dataset, the risk of de-identification of individual patients is not possible. Synthetic data enables maximum data utility while maintaining patient privacy.

discover synthetic data →

 
backgrounds-17-x.png

request a demo

Ready when you are.

Connect with our team and discover how MDClone can unlock the power of dynamic data exploration for life sciences.